ArticleInternational journal of molecular sciences2026

First-in-Class Immuno-Oncology Drug APG157DS Repolarizes Innate Immune Cells and Induces Durable Remission in a Syngeneic Glioblastoma Model.

Shubhasmita Mohapatra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.